Allogene Therapeutics Ownership | Who Owns Allogene Therapeutics?
Allogene Therapeutics Ownership Summary
Allogene Therapeutics is owned by 131.06% institutional investors, 11.03% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.55% of ALLO shares. American Funds SMALLCAP World A is the top mutual fund, with 5.10% of its assets in Allogene Therapeutics shares.
ALLO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Allogene Therapeutics | 131.06% | 11.03% | -42.10% |
| Sector | Healthcare Stocks | 50.59% | 12.40% | 37.01% |
| Industry | Biotech Stocks | 49.10% | 12.14% | 38.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 30.15M | 12.55% | $62.71M |
| Blackrock | 16.45M | 9.72% | $38.32M |
| Frazier life sciences management | 22.45M | 9.34% | $46.69M |
| Pfizer | 22.03M | 9.17% | $46.93M |
| State street | 19.03M | 7.92% | $39.57M |
| Tpg gp a | 18.72M | 7.79% | $38.93M |
| Sio capital management | 13.32M | 5.54% | $27.71M |
| Primecap management co/ca/ | 13.12M | 5.46% | $27.30M |
| Vanguard capital management | 12.17M | 5.06% | $25.31M |
| Fmr | 12.01M | 5.00% | $24.98M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pfizer | 22.03M | 27.55% | $46.93M |
| Vida ventures advisors | 1.80M | 7.59% | $2.23M |
| Sio capital management | 13.32M | 4.59% | $27.71M |
| Wildcat capital management | 2.92M | 2.66% | $6.08M |
| Patient square capital lp | 5.05M | 1.63% | $10.50M |
| Frazier life sciences management | 22.45M | 1.02% | $46.69M |
| Dafna capital management | 2.00M | 0.79% | $4.16M |
| Tpg gp a | 18.72M | 0.78% | $38.93M |
| Harold davidson & associates | 281.52K | 0.25% | $585.57K |
| Boxer capital management | 1.50M | 0.23% | $3.12M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Frazier life sciences management | 22.45M | 1.02% | 18.65M |
| Sio capital management | 13.32M | 4.59% | 13.32M |
| Blackrock funding, inc. /de | 30.15M | 0.00% | 11.06M |
| Fmr | 12.01M | 0.00% | 10.42M |
| State street | 19.03M | 0.00% | 10.37M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | - | - | -11.15M |
| Lynx1 capital management lp | 546.12K | 0.14% | -10.51M |
| Darwin global management | - | - | -10.48M |
| Boxer capital | - | - | -3.85M |
| Foresite capital management vi | - | - | -2.88M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sio capital management | 13.32M | 4.59% | 13.32M | $27.71M |
| Walleye capital | 3.27M | 0.02% | 3.27M | $6.80M |
| Rtw investments, lp | 3.25M | 0.06% | 3.25M | $6.76M |
| Ghisallo capital management | 3.00M | 0.12% | 3.00M | $6.24M |
| Sixth street partners management company | 2.27M | 0.00% | 2.27M | $4.73M |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -27.00 |
| Capital performance advisors llp | -41.00 |
| Dunhill financial | -70.00 |
| Federation des caisses desjardins du quebec | -100.00 |
| Private wealth management group | -140.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 213 | -0.47% | 314,931,214 | 70.98% | 131 | 2.23% | 130 | -2.99% | 50 | 31.58% |
| Mar 31, 2026 | 119 | -32.00% | 82,438,846 | -49.31% | 37 | 0.70% | 68 | -16.05% | 22 | -51.11% |
| Dec 31, 2025 | 108 | -37.93% | 99,292,779 | -38.89% | 44 | 0.81% | 46 | -51.06% | 31 | -16.22% |
| Sep 30, 2025 | 166 | 8.50% | 162,395,329 | -2.90% | 74 | 1.27% | 85 | 26.87% | 37 | -11.90% |
| Jun 30, 2025 | 160 | -6.98% | 183,929,908 | -6.69% | 84 | 1.00% | 66 | -27.47% | 47 | 14.63% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 11.15M | 5.10% | -1.12M |
| State Street® SPDR® S&P® Biotech ETF | 11.95M | 3.46% | 27.45K |
| Fidelity Select Biotechnology | 10.35M | 3.00% | 800.00K |
| Vanguard Capital Opportunity Inv | 9.39M | 2.72% | 4.02M |
| Vanguard Morn Total Stk Mkt Idx Investor | 8.67M | 2.51% | 238.80K |
| Vanguard Total Stock Mkt Idx Inv | 8.67M | 2.51% | 238.80K |
| Vanguard MStar Total Stk Mkt Idx Invest | 8.67M | 2.51% | - |
| Fidelity Growth Compy Commingled Pl O | 4.58M | 2.19% | - |
| Vanguard US Total Market Shares ETF | 4.34M | 2.00% | - |
| iShares Russell 2000 ETF | 6.77M | 1.96% | -120.19K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Douglas Earl Martin | SVP, General Counsel | Sell | $62.96K |
| Apr 21, 2026 | Yoshiyama Annie | SVP, Finance | Sell | $22.14K |
| Mar 31, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | $7.17K |
| Mar 16, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | $11.94K |
| Mar 16, 2026 | Chang David D | President and CEO | Sell | $117.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 11 |
| 2025 Q4 | - | 2 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 9 |
ALLO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools